The Latest
Op-EdsPrice Controls Kill More Than Innovation
Sanders’ pharmaceutical price controls will not only reduce future drug development but also cripple the generics industry.
Press ReleaseCitizens Against Government Waste Names Sen. Elizabeth Warren April 2024 Porker of the Month
Sen. Warren is our April 2024 Porker of the Month for pushing the IRS to prepare and collect everyone’s taxes.
The WasteWatcherThe IRS Continues to Live Down to its Reputation
If past is prologue, IRS' latest effort to stymie competition among tax preparers will end in user dissatisfaction and lawsuits
The WasteWatcherLives Hang in the Balance While the FDA Bureaucracy Churns
The government red tape contributing to the backlog of PMTAs has put consumers at risk with illicit products.
Op-EdsVirginia Fights for Affordable, Accessible Broadband
Virginia’s firm stand on BEAD funding serves as a beacon for the states.
The WasteWatcherACP Funding Expiration Will Affect States’ Broadband Rate Regulation
Ending ACP will complicate and delay state efforts to expand affordable internet access.
The WasteWatcherFTC Chair Khan Should Focus on Production and Prices Instead of Political Pressure
Mergers should be reviewed based on their benefits to consumers, not pressure from members of Congress.
The WasteWatcherThe FCC's Not So Merry-Go-Round of Net Neutrality
The Biden administration’s creates uncertainty for future of broadband deployments across America and wastes taxpayer resources.
Press ReleaseJoint Statement by CAGW President Tom Schatz and ITPC Executive Director Deborah Collier on Net Neutrality Rules
Today, the FCC announced it would be voting on reinstating net neutrality rules at its April 25, 2024, monthly meeting.
Op-EdsA ‘D’ for the USPS Delivering for America plan
The USPS delivers at least one thing consistently. It has lost money in every quarter since 2007.
The WasteWatcherPresident Biden's Budget Will Raise Taxes and Federal Debt
President Biden's FY 2025 budget would increase government spending, restore IRS funding, and raise taxes
The 340B Drug Pricing Program Needs a New Prescription
Federal healthcare programs are often well-intended but end up costing more than expected and become subject to waste, fraud, abuse, and mismanagement.
